Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-14

Clinical Trial Update: To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel [Phase 3]

View source ↗

Summary

Phase 3 trial comparing clindamycin phosphate 1.2% / benzoyl peroxide 5% gel to DUAC gel in acne vulgaris; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel
  • Duac Gel (benzoyl peroxide/clindamycin)

Snippet

Sponsor: Zydus Lifesciences Limited | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2020-09-14